vs
ASTRONICS CORP（ATRO）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
ASTRONICS CORP的季度营收约是再鼎医药的1.9倍（$240.1M vs $127.1M），再鼎医药同比增速更快（17.1% vs 15.1%），ASTRONICS CORP自由现金流更多（$15.8M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 13.9%）
Astronics Corporation是一家成立于1968年的美国航空航天电子企业，总部位于纽约州东奥罗拉，在纳斯达克上市，股票代码为ATRO。该公司专注于军用、商用及公务机的照明与电子系统集成业务，同时还提供半导体测试系统，在相关领域拥有较高知名度。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
ATRO vs ZLAB — 直观对比
营收规模更大
ATRO
是对方的1.9倍
$127.1M
营收增速更快
ZLAB
高出2.0%
15.1%
自由现金流更多
ATRO
多$42.5M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $240.1M | $127.1M |
| 净利润 | — | — |
| 毛利率 | 33.3% | 51.0% |
| 营业利润率 | 14.8% | -54.6% |
| 净利率 | — | — |
| 营收同比 | 15.1% | 17.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.82 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATROZLAB
| Q4 25 | $240.1M | $127.1M | ||
| Q3 25 | $211.4M | $115.4M | ||
| Q2 25 | $204.7M | $109.1M | ||
| Q1 25 | $205.9M | $105.7M | ||
| Q4 24 | $208.5M | $108.5M | ||
| Q3 24 | $203.7M | $101.8M | ||
| Q2 24 | $198.1M | $100.1M | ||
| Q1 24 | $185.1M | $87.1M |
净利润ATROZLAB
| Q4 25 | — | — | ||
| Q3 25 | $-11.1M | $-36.0M | ||
| Q2 25 | $1.3M | $-40.7M | ||
| Q1 25 | $9.5M | $-48.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-11.7M | $-41.7M | ||
| Q2 24 | $1.5M | $-80.3M | ||
| Q1 24 | $-3.2M | $-53.5M |
毛利率ATROZLAB
| Q4 25 | 33.3% | 51.0% | ||
| Q3 25 | 30.5% | 59.5% | ||
| Q2 25 | 25.8% | 60.6% | ||
| Q1 25 | 29.5% | 63.6% | ||
| Q4 24 | 29.8% | 61.5% | ||
| Q3 24 | 27.1% | 64.1% | ||
| Q2 24 | 28.0% | 64.9% | ||
| Q1 24 | 25.7% | 61.4% |
营业利润率ATROZLAB
| Q4 25 | 14.8% | -54.6% | ||
| Q3 25 | 10.9% | -42.3% | ||
| Q2 25 | 2.3% | -50.3% | ||
| Q1 25 | 6.4% | -53.3% | ||
| Q4 24 | 4.3% | -62.6% | ||
| Q3 24 | 4.1% | -66.6% | ||
| Q2 24 | 3.8% | -76.0% | ||
| Q1 24 | 0.9% | -80.7% |
净利率ATROZLAB
| Q4 25 | — | — | ||
| Q3 25 | -5.2% | -31.2% | ||
| Q2 25 | 0.6% | -37.3% | ||
| Q1 25 | 4.6% | -45.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -5.8% | -40.9% | ||
| Q2 24 | 0.8% | -80.2% | ||
| Q1 24 | -1.7% | -61.4% |
每股收益（稀释后）ATROZLAB
| Q4 25 | $0.82 | $-0.05 | ||
| Q3 25 | $-0.31 | $-0.03 | ||
| Q2 25 | $0.04 | $-0.04 | ||
| Q1 25 | $0.26 | $-0.04 | ||
| Q4 24 | $-0.07 | $-0.09 | ||
| Q3 24 | $-0.34 | $-0.04 | ||
| Q2 24 | $0.04 | $-0.08 | ||
| Q1 24 | $-0.09 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.2M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $140.1M | $715.5M |
| 总资产 | $706.7M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATROZLAB
| Q4 25 | $18.2M | $689.6M | ||
| Q3 25 | $13.5M | $717.2M | ||
| Q2 25 | $13.5M | $732.2M | ||
| Q1 25 | $24.8M | $757.3M | ||
| Q4 24 | $9.3M | $779.7M | ||
| Q3 24 | $5.2M | $616.1M | ||
| Q2 24 | $2.9M | $630.0M | ||
| Q1 24 | $5.3M | $650.8M |
股东权益ATROZLAB
| Q4 25 | $140.1M | $715.5M | ||
| Q3 25 | $108.9M | $759.9M | ||
| Q2 25 | $271.6M | $791.7M | ||
| Q1 25 | $266.8M | $810.8M | ||
| Q4 24 | $256.1M | $840.9M | ||
| Q3 24 | $249.2M | $667.7M | ||
| Q2 24 | $257.9M | $704.2M | ||
| Q1 24 | $251.7M | $762.2M |
总资产ATROZLAB
| Q4 25 | $706.7M | $1.2B | ||
| Q3 25 | $682.2M | $1.2B | ||
| Q2 25 | $646.7M | $1.2B | ||
| Q1 25 | $662.2M | $1.2B | ||
| Q4 24 | $648.8M | $1.2B | ||
| Q3 24 | $651.6M | $985.3M | ||
| Q2 24 | $644.9M | $987.4M | ||
| Q1 24 | $630.0M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.6M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $15.8M | $-26.7M |
| 自由现金流率自由现金流/营收 | 6.6% | -21.0% |
| 资本支出强度资本支出/营收 | 4.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $43.1M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流ATROZLAB
| Q4 25 | $27.6M | $-26.0M | ||
| Q3 25 | $34.2M | $-32.0M | ||
| Q2 25 | $-7.6M | $-31.0M | ||
| Q1 25 | $20.6M | $-61.7M | ||
| Q4 24 | $26.4M | $-55.8M | ||
| Q3 24 | $8.4M | $-26.8M | ||
| Q2 24 | $-6.3M | $-42.2M | ||
| Q1 24 | $2.0M | $-90.1M |
自由现金流ATROZLAB
| Q4 25 | $15.8M | $-26.7M | ||
| Q3 25 | $21.0M | $-35.0M | ||
| Q2 25 | $-12.2M | $-33.9M | ||
| Q1 25 | $18.5M | $-63.2M | ||
| Q4 24 | $23.2M | $-58.4M | ||
| Q3 24 | $6.5M | $-28.2M | ||
| Q2 24 | $-8.1M | $-42.9M | ||
| Q1 24 | $439.0K | $-91.1M |
自由现金流率ATROZLAB
| Q4 25 | 6.6% | -21.0% | ||
| Q3 25 | 9.9% | -30.4% | ||
| Q2 25 | -6.0% | -31.1% | ||
| Q1 25 | 9.0% | -59.9% | ||
| Q4 24 | 11.1% | -53.8% | ||
| Q3 24 | 3.2% | -27.7% | ||
| Q2 24 | -4.1% | -42.9% | ||
| Q1 24 | 0.2% | -104.5% |
资本支出强度ATROZLAB
| Q4 25 | 4.9% | 0.5% | ||
| Q3 25 | 6.2% | 2.6% | ||
| Q2 25 | 2.2% | 2.6% | ||
| Q1 25 | 1.0% | 1.5% | ||
| Q4 24 | 1.5% | 2.4% | ||
| Q3 24 | 0.9% | 1.3% | ||
| Q2 24 | 0.9% | 0.7% | ||
| Q1 24 | 0.9% | 1.1% |
现金转化率ATROZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -5.81× | — | ||
| Q1 25 | 2.17× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.08× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
